Life Sciences Compensation and Leadership Consulting
We help organizations identify, develop, and reward high-performance leadership teams.
Meet the Expert
Robert James
Managing Director | Los Angeles
Rob James is a managing director with Pearl Meyer with almost 15 years of experience in executive compensation and finance. He serves as a trusted advisor to boards and senior management at public and private firms across North America. He works with companies in all industries, but he has in-depth knowledge and expertise in designing compensations strategies for organizations in life sciences and technology, particularly emerging and high growth companies that are pursuing or have recently completed a M&A transaction or public offering.
Biopharma Peer Groups: Data-Driven Insights for Compensation Committees
How We Partner With You
We help boards and senior leaders motivate and reward their talent creating world-class organizations.
We are your trusted advisors
Whether your company is focused on a new therapeutic or equipment that allows a hospital unit to run more efficiently, our consultants are experienced in understanding the nuance of your unique business and its long-term strategy. We use that knowledge to create a holistic view of your organization, its culture, and its human capital strategy.
We provide tailored solutions
Our consultants connect business and leadership strategies, analytics, and compliance frameworks to solve problems. The result is a compensation program design that is tailored to your unique circumstances and is aligned with how you manage and develop the talent within your organization.
Together, we see goal-oriented results
We believe in a partnership approach. Building trust and facilitating open and productive communication between management, the board, and your Pearl Meyer team is the key to achieving success. We help construct a shared, proactive, and goal-oriented vision for your compensation and leadership programs that produces results, not surprises.
Approach & Partnership
The Pillars of Success
Key Drivers
Business Strategy
- Mission & Vision
- Organization Culture
Pearl Meyer's Role
Executive Compensation
- Develop Philosophy
- Assess Competitiveness
- Design Programs
Leadership
- Develop Leadership Framework
- Assess Leadership & Board Effectiveness
- Coach & Develop
Communications & Disclosures
Key Outcomes
Exceptional Business Results
- High Performance Leadership & Culture
The Compensation Committee's Role in Driving a Successful People Strategy
Biopharma Peer Groups: Data-Driven Insights for Compensation Committees
Preparing for Potential SPAC Mergers in Biotech
Implications of Glass Lewis’ Updated Pay-for-Performance Methodology for Life Sciences Companies
Managing Through Today’s Chaos in the Life Sciences Sector – Look To Your Board
What to Do When Salary Compression Pinches the Life Sciences Industry
Hot Topics in Private Biotech
Biotech Companies: Don’t Skip the Compensation Philosophy Step
Inside the Pay Structure: Employee Compensation at Life Sciences Companies
One Small Change for a More Durable Biotech Equity Pool
Transitioning From Stock Options to RSUs
The Price of Progress: Compensation Considerations in Life Sciences Transactions
The DNA of Pay: Evolving Compensation in a New Era of Life Sciences
Rethinking Equity Plan Proposals in Biotech
Enhanced Severance as a Retention Tool in Life Sciences
Designing an Effective Bonus Plan for Early-Stage Biotech Companies
Getting a Jump on Salary Budgets at Life Sciences Companies
Severance Benefits in Emerging Biotech Companies
Peer Group Development for Life Sciences Companies
Trends in Director Pay Litigation Against Biotech Companies
Biopharma IPOs: Trends in Executive Compensation Planning and Design
Biopharma Fundraising and the Related Compensation Considerations
Key Considerations for Biopharma Equity Plan Amendments
Biotech Compensation Trends: Common Questions for 2024
Setting Annual Incentive Compensation Goals in Biotech
The Impact of Biotech Commercialization on Executive Compensation
The Impact on Biotech: New Insider Trading and Related Disclosure Rules
What Growth-Stage Biotech and Pharma Companies Need to Know About the PvP Rules
Juggling Biotech Equity Grant Size, Dilution, and Retention
Option Repricing or Exchanges in Development Biotech
Beyond Equity: Strategies to Retain Top Life Sciences Talent
Biotech Layoffs: Ideas for Creating a Fair Compensation Plan
Winning the Talent War in Life Sciences
We believe in the power of connecting compensation and leadership strategy to help our clients enable and reward individual and organizational success.
Pearl Meyer is a powerhouse of both survey and proxy data. Our survey team produces over 50 annual compensation surveys and our partner, Main Data Group, offers public company governance and compensation data.